You're saying that you'd be able to make a more knowledgeable and informed decision on the trial data than Novartis? If so, we need to have a good chat.
Ann: Update on Novartis Agreement, page-423
-
- There are more pages in this discussion • 428 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $12.21M | 10.53M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5717 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 196219 | 22 |
View Market Depth
| Last trade - 15.35pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |